-
Product Insights
NewArthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Arthralgia Clinical Trial Report Overview A total of 713 Arthralgia clinical trials were conducted as of March 2024. The Arthralgia clinical trial report provides a comprehensive understanding of the Arthralgia clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·       North America ·       Europe ·       Asia-Pacific ·       ...
-
Product Insights
Trigeminal Neuralgia (Tic Douloureux) – Drugs In Development, 2023
Global Markets Direct’s, ‘Trigeminal Neuralgia (Tic Douloureux) - Drugs In Development, 2023’, provides an overview of the Trigeminal Neuralgia (Tic Douloureux) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Trigeminal Neuralgia (Tic Douloureux), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Polymyalgia Rheumatica (PMR) – Drugs In Development, 2023
Global Markets Direct’s, ‘Polymyalgia Rheumatica (PMR) - Drugs In Development, 2023’, provides an overview of the Polymyalgia Rheumatica (PMR) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Polymyalgia Rheumatica (PMR), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Cluster Headache Syndrome (Cluster Headache) – Drugs In Development, 2023
Global Markets Direct’s, ‘Cluster Headache Syndrome (Cluster Headache) - Drugs In Development, 2023’, provides an overview of the Cluster Headache Syndrome (Cluster Headache) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cluster Headache Syndrome (Cluster Headache), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Fibromyalgia (Fibromyalgia Syndrome) – Drugs In Development, 2023
Global Markets Direct’s, ‘Fibromyalgia (Fibromyalgia Syndrome) - Drugs In Development, 2023’, provides an overview of the Fibromyalgia (Fibromyalgia Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fibromyalgia (Fibromyalgia Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Postherpetic Neuralgia – Drugs In Development, 2023
Global Markets Direct’s, ‘Postherpetic Neuralgia - Drugs In Development, 2023’, provides an overview of the Postherpetic Neuralgia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Postherpetic Neuralgia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Interstitial Cystitis Clinical Trials Overview The report provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome) clinical trial scenario and top-line data relating to the clinical trials. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. Key Regions ·       North America ·       Asia-Pacific ·       Europe ·       ...
-
Product Insights
Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Overview The Trigeminal Neuralgia (Tic Douloureux) clinical trial report consists of 129 trials. The report provides an overview of the Trigeminal Neuralgia (Tic Douloureux) clinical trials scenario. The report provides top-line data relating to the clinical trials on Trigeminal Neuralgia (Tic Douloureux). It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 &...
-
Sector Analysis
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
CLBP Marketed and Pipeline Drugs Report Overview Chronic low back pain (CLBP) is defined as pain that continues for 12 weeks or longer, even after an initial injury or underlying cause of acute low back pain (BP) has been treated. It represents the second-leading cause of disability worldwide and is a major health and economic problem. CLBP is a complex disease with high heterogeneity and is increasingly dubbed a mixed pain syndrome with neuropathic and injurious components. CLBP develops in...
-
Product Insights
Postherpetic Neuralgia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Postherpetic Neuralgia Clinical Trials Market Report Overview The Postherpetic Neuralgia Clinical Trial provides an overview of Postherpetic Neuralgia Clinical trials scenario. The report provides top line data relating to the clinical trials on Postherpetic Neuralgia. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.